| Ireland | 001-37757 | 98-1328821 | ||||||
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification Number) | ||||||
|
25 North Wall Quay
Dublin 1, Ireland D01 H104
| ||
| (Address of principal executive offices) | ||
| Not applicable | ||
| Title of class | Trading symbol(s) | Name of exchange on which registered | ||||||||||||
| Ordinary Shares, par value $0.001 | ADNT | New York Stock Exchange | ||||||||||||
| EXHIBIT INDEX | ||||||||
| Exhibit No. | Exhibit Description | |||||||
| 99.1 | ||||||||
| 104 | Cover Page Interactive Data File (the Cover Page Interactive Data File is embedded within the Inline XBRL document). |
|||||||
| ADIENT PLC | ||||||||
Date: May 6, 2026 |
By: | /s/ Heather M. Tiltmann | ||||||
| Name: | Heather M. Tiltmann | |||||||
| Title: | Executive Vice President, Chief Legal and Human Resources Officer, and Corporate Secretary |
|||||||




| Three Months Ended March 31, |
||||||||||||||
| (in millions, except per share data) | 2026 | 2025 | ||||||||||||
| Net sales | $ | 3,865 | $ | 3,611 | ||||||||||
| Cost of sales | 3,608 | 3,350 | ||||||||||||
| Gross profit | 257 | 261 | ||||||||||||
| Selling, general and administrative expenses | 138 | 144 | ||||||||||||
| Restructuring and impairment costs | 5 | 351 | ||||||||||||
| Equity income | 13 | 18 | ||||||||||||
| Earnings (loss) before interest and income taxes | 127 | (216) | ||||||||||||
| Net financing charges | 48 | 48 | ||||||||||||
| Other pension expense | 3 | 1 | ||||||||||||
| Income (loss) before income taxes | 76 | (265) | ||||||||||||
| Income tax provision | 32 | 48 | ||||||||||||
| Net income (loss) | 44 | (313) | ||||||||||||
| Income attributable to noncontrolling interests | 17 | 22 | ||||||||||||
| Net income (loss) attributable to Adient | $ | 27 | $ | (335) | ||||||||||
| Diluted earnings (loss) per share | $ | 0.34 | $ | (3.99) | ||||||||||
| Shares outstanding at period end | 78.4 | 84.0 | ||||||||||||
| Diluted weighted average shares | 79.3 | 84.0 | ||||||||||||
| March 31, | September 30, | |||||||||||||
| (in millions) | 2026 | 2025 | ||||||||||||
| Assets | ||||||||||||||
| Cash and cash equivalents | $ | 831 | $ | 958 | ||||||||||
Accounts receivable - net |
2,032 | 1,873 | ||||||||||||
| Inventories | 735 | 695 | ||||||||||||
| Other current assets | 649 | 607 | ||||||||||||
| Current assets | 4,247 | 4,133 | ||||||||||||
| Property, plant and equipment - net | 1,384 | 1,409 | ||||||||||||
| Goodwill | 1,798 | 1,807 | ||||||||||||
| Other intangible assets - net | 305 | 319 | ||||||||||||
| Investments in partially-owned affiliates | 301 | 276 | ||||||||||||
| Assets held for sale | 12 | 9 | ||||||||||||
| Other noncurrent assets | 985 | 1,001 | ||||||||||||
| Total assets | $ | 9,032 | $ | 8,954 | ||||||||||
| Liabilities and Shareholders' Equity | ||||||||||||||
| Short-term debt | $ | 9 | $ | 11 | ||||||||||
| Accounts payable and accrued expenses | 3,113 | 2,942 | ||||||||||||
| Other current liabilities | 748 | 734 | ||||||||||||
| Current liabilities | 3,870 | 3,687 | ||||||||||||
| Long-term debt | 2,379 | 2,386 | ||||||||||||
| Other noncurrent liabilities | 695 | 723 | ||||||||||||
| Redeemable noncontrolling interests | 71 | 95 | ||||||||||||
| Shareholders' equity attributable to Adient | 1,713 | 1,766 | ||||||||||||
| Noncontrolling interests | 304 | 297 | ||||||||||||
| Total liabilities and shareholders' equity | $ | 9,032 | $ | 8,954 | ||||||||||
| Three Months Ended March 31, |
||||||||||||||
| (in millions) | 2026 | 2025 | ||||||||||||
| Operating Activities | ||||||||||||||
| Net income (loss) attributable to Adient | $ | 27 | $ | (335) | ||||||||||
| Income attributable to noncontrolling interests | 17 | 22 | ||||||||||||
| Net income (loss) | 44 | (313) | ||||||||||||
| Adjustments to reconcile net income (loss) to cash provided (used) by operating activities: | ||||||||||||||
| Depreciation | 68 | 67 | ||||||||||||
| Amortization of intangibles | 12 | 12 | ||||||||||||
| Pension and postretirement benefit expense | 5 | 3 | ||||||||||||
| Pension and postretirement contributions, net | (8) | (5) | ||||||||||||
| Equity in earnings of partially-owned affiliates, net of dividends received | 15 | 29 | ||||||||||||
| Deferred income taxes | 1 | 10 | ||||||||||||
| Non-cash impairment charges | — | 333 | ||||||||||||
| Equity-based compensation | 9 | 5 | ||||||||||||
| Other | 1 | 5 | ||||||||||||
| Changes in assets and liabilities: | ||||||||||||||
| Receivables | (411) | (439) | ||||||||||||
| Inventories | 17 | 18 | ||||||||||||
| Other assets | 15 | (5) | ||||||||||||
| Accounts payable and accrued liabilities | 336 | 223 | ||||||||||||
| Accrued income taxes | (23) | 12 | ||||||||||||
| Cash provided (used) by operating activities | 81 | (45) | ||||||||||||
| Investing Activities | ||||||||||||||
| Capital expenditures | (73) | (45) | ||||||||||||
| Sale of property, plant and equipment | — | 2 | ||||||||||||
| Investments in partially-owned affiliates | (2) | — | ||||||||||||
| Other | — | (1) | ||||||||||||
| Cash used by investing activities | (75) | (44) | ||||||||||||
| Financing Activities | ||||||||||||||
| Drawdown of ABL revolver and other bank borrowings | 150 | 2 | ||||||||||||
| Repayment of ABL revolver and other bank borrowings | (152) | — | ||||||||||||
| Issuance of long-term debt | — | 795 | ||||||||||||
| (Repayment) of long-term debt | (3) | (797) | ||||||||||||
| Debt financing costs | (1) | (12) | ||||||||||||
| Dividends paid to noncontrolling interests | (1) | (35) | ||||||||||||
| Cash used by financing activities | (7) | (47) | ||||||||||||
| Effect of exchange rate changes on cash and cash equivalents | (23) | 30 | ||||||||||||
| Decrease in cash and cash equivalents | $ | (24) | $ | (106) | ||||||||||
| (in millions) | Three months ended March 31, 2026 | |||||||||||||||||||||||||||||||
| Americas | EMEA | Asia | Corporate/Eliminations | Consolidated | ||||||||||||||||||||||||||||
| Net sales | $ | 1,884 | $ | 1,272 | $ | 734 | $ | (25) | $ | 3,865 | ||||||||||||||||||||||
| Adjusted EBITDA | $ | 109 | $ | 45 | $ | 92 | $ | (23) | $ | 223 | ||||||||||||||||||||||
| Adjusted EBITDA margin | 5.8 | % | 3.5 | % | 12.5 | % | N/A | 5.8 | % | |||||||||||||||||||||||
| Three months ended March 31, 2025 | ||||||||||||||||||||||||||||||||
| Americas | EMEA | Asia | Corporate/Eliminations | Consolidated | ||||||||||||||||||||||||||||
| Net sales | $ | 1,699 | $ | 1,231 | $ | 707 | $ | (26) | $ | 3,611 | ||||||||||||||||||||||
| Adjusted EBITDA | $ | 94 | $ | 50 | $ | 110 | $ | (21) | $ | 233 | ||||||||||||||||||||||
| Adjusted EBITDA margin | 5.5 | % | 4.1 | % | 15.6 | % | N/A | 6.5 | % | |||||||||||||||||||||||
| Three Months Ended March 31, |
||||||||||||||
| (in millions) | 2026 | 2025 | ||||||||||||
| Adjusted EBITDA | ||||||||||||||
| Americas | $ | 109 | $ | 94 | ||||||||||
| EMEA | 45 | 50 | ||||||||||||
| Asia | 92 | 110 | ||||||||||||
| Subtotal | 246 | 254 | ||||||||||||
Corporate-related costs (1) |
(23) | (21) | ||||||||||||
Restructuring and impairment costs (2) |
(5) | (351) | ||||||||||||
Purchase accounting amortization (3) |
(12) | (12) | ||||||||||||
Restructuring related activities (4) |
(6) | (5) | ||||||||||||
| Equity based compensation | (9) | (5) | ||||||||||||
| Depreciation | (68) | (67) | ||||||||||||
Other items (5) |
4 | (9) | ||||||||||||
| Earnings (loss) before interest and income taxes | $ | 127 | $ | (216) | ||||||||||
| Net financing charges | (48) | (48) | ||||||||||||
| Other pension expense | (3) | (1) | ||||||||||||
| Income (loss) before income taxes | $ | 76 | $ | (265) | ||||||||||
| Three Months Ended March 31, |
||||||||||||||
| (in millions, except per share data) | 2026 | 2025 | ||||||||||||
| Income available to shareholders | ||||||||||||||
| Net income (loss) attributable to Adient | $ | 27 | $ | (335) | ||||||||||
| Weighted average shares outstanding | ||||||||||||||
| Basic weighted average shares outstanding | 78.4 | 84.0 | ||||||||||||
| Effect of dilutive securities: | ||||||||||||||
| Unvested restricted stock and unvested performance share awards | 0.9 | — | ||||||||||||
| Diluted weighted average shares outstanding | 79.3 | 84.0 | ||||||||||||
| Earnings (loss) per share: | ||||||||||||||
| Basic | $ | 0.34 | $ | (3.99) | ||||||||||
| Diluted | $ | 0.34 | $ | (3.99) | ||||||||||
| (a) | Adjusted EBIT is defined as earnings (loss) before income taxes and noncontrolling interests excluding net financing charges, restructuring, impairment and related costs, purchase accounting amortization, transaction gains/losses, other significant non-recurring items, and net mark-to-market adjustments on pension and postretirement plans. Adjusted EBIT margin is adjusted EBIT as a percentage of net sales. | ||||
| (b) | Adjusted EBITDA is defined as adjusted EBIT excluding depreciation and equity based compensation. Certain corporate-related costs are not allocated to the business segments in determining adjusted EBITDA. Adjusted EBITDA margin is adjusted EBITDA as a percentage of net sales. | ||||
| (c) | Adjusted net income attributable to Adient is defined as net income (loss) attributable to Adient excluding restructuring, impairment and related costs, purchase accounting amortization, transaction gains/losses, other significant non-recurring items, net mark-to-market adjustments on pension and postretirement plans, the tax impact of these items and other discrete tax charges/benefits. | ||||
| (d) | Adjusted income tax expense is defined as income tax expense adjusted for the tax effect of the adjustments to income before income taxes and other discrete tax changes/benefits. Adjusted effective tax rate is defined as adjusted income tax provision as a percentage of adjusted income before income taxes. | ||||
| (e) | Adjusted diluted earnings per share is defined as adjusted net income attributable to Adient divided by diluted weighted average shares. | ||||
| (f) | Adjusted equity income is defined as equity income excluding amortization of Adient's intangible assets related to its non-consolidated joint ventures and other unusual or non-recurring items impacting equity income. | ||||
| (g) | Adjusted interest expense is defined as net financing charges excluding unusual or one-time items impacting interest expense. | ||||
| (h) | Free cash flow is defined as cash provided by operating activities less capital expenditures. | ||||
| (i) | Net debt is calculated as total debt (short-term and long-term) less cash and cash equivalents. | ||||
| (j) | Net leverage ratio is calculated as net debt divided by adjusted EBITDA for the last four quarters. | ||||
| Three Months Ended March 31, |
||||||||||||||
| (in millions) | 2026 | 2025 | ||||||||||||
| Net income (loss) | $ | 44 | $ | (313) | ||||||||||
| Net financing charges | 48 | 48 | ||||||||||||
| Other pension expense | 3 | 1 | ||||||||||||
| Income tax expense | 32 | 48 | ||||||||||||
| Earnings (loss) before interest and income taxes (EBIT) | $ | 127 | $ | (216) | ||||||||||
| EBIT adjustments: | ||||||||||||||
Restructuring and impairment costs (2) |
5 | 351 | ||||||||||||
Purchase accounting amortization (3) |
12 | 12 | ||||||||||||
Restructuring related activities (4) |
6 | 5 | ||||||||||||
Other items (5) |
(4) | 9 | ||||||||||||
| EBIT adjustments total | 19 | 377 | ||||||||||||
| Adjusted EBIT | $ | 146 | $ | 161 | ||||||||||
| EBITDA adjustments: | ||||||||||||||
| Depreciation | 68 | 67 | ||||||||||||
| Equity based compensation | 9 | 5 | ||||||||||||
| Adjusted EBITDA | $ | 223 | $ | 233 | ||||||||||
| Net sales | $ | 3,865 | $ | 3,611 | ||||||||||
| Net income (loss) as % of net sales | 1.1 | % | (8.7) | % | ||||||||||
| EBIT as % of net sales | 3.3 | % | (6.0) | % | ||||||||||
| Adjusted EBIT as % of net sales | 3.8 | % | 4.5 | % | ||||||||||
| Adjusted EBITDA as % of net sales | 5.8 | % | 6.5 | % | ||||||||||
| Three Months Ended March 31, |
||||||||||||||
| (in millions) | 2026 | 2025 | ||||||||||||
| Net income (loss) attributable to Adient | $ | 27 | $ | (335) | ||||||||||
| Net income adjustments: | ||||||||||||||
| EBIT adjustments total - see table (a) & (b) | 19 | 377 | ||||||||||||
| Tax impact of EBIT adjustments and other tax items - see table (d) | (6) | 15 | ||||||||||||
| Pension actuarial loss | 2 | — | ||||||||||||
| Write off of deferred financing costs upon repurchase of debt | — | 2 | ||||||||||||
Impact of adjustments on noncontrolling interests (6) |
(1) | (1) | ||||||||||||
| Net income adjustments total | 14 | 393 | ||||||||||||
| Adjusted net income attributable to Adient | $ | 41 | $ | 58 | ||||||||||
| Three months ended March 31, | ||||||||||||||||||||||||||||||||||||||
| 2026 | 2025 | |||||||||||||||||||||||||||||||||||||
| (in millions, except effective tax rate) | Income before income taxes | Income tax expense (benefit) | Effective tax rate | Income before income taxes | Income tax expense (benefit) | Effective tax rate | ||||||||||||||||||||||||||||||||
| As reported | $ | 76 | $ | 32 | 42.1 | % | $ | (265) | $ | 48 | (18.1) | % | ||||||||||||||||||||||||||
| Adjustments | ||||||||||||||||||||||||||||||||||||||
| EBIT adjustments - see table (a) & (b) | 19 | 3 | 15.8 | % | 377 | 16 | 4.2 | % | ||||||||||||||||||||||||||||||
| Tax audit closures and statute expirations | — | 3 | nm | — | 1 | nm | ||||||||||||||||||||||||||||||||
| UTP establishments and interest | — | (2) | nm | — | (11) | nm | ||||||||||||||||||||||||||||||||
| NOL DTA adjustments | — | — | nm | — | (19) | nm | ||||||||||||||||||||||||||||||||
| Pension actuarial loss | 2 | — | — | % | — | — | nm | |||||||||||||||||||||||||||||||
| Net financing charges | — | — | nm | 2 | — | — | % | |||||||||||||||||||||||||||||||
| Other | — | 2 | nm | — | (2) | nm | ||||||||||||||||||||||||||||||||
| Subtotal of adjustments | 21 | 6 | 28.6 | % | 379 | (15) | (4.0) | % | ||||||||||||||||||||||||||||||
| As adjusted | $ | 97 | $ | 38 | 39.2 | % | $ | 114 | $ | 33 | 28.9 | % | ||||||||||||||||||||||||||
| Three Months Ended March 31, |
||||||||||||||
| (in millions, except per share data) | 2026 | 2025 | ||||||||||||
| Numerator: | ||||||||||||||
| Adjusted net income attributable to Adient - see table (c) | $ | 41 | $ | 58 | ||||||||||
| Denominator: | ||||||||||||||
| Basic weighted average shares outstanding | 78.4 | 84.0 | ||||||||||||
| Effect of dilutive securities: | ||||||||||||||
| Unvested restricted stock and unvested performance share awards | 0.9 | 0.1 | ||||||||||||
| Diluted weighted average shares outstanding | 79.3 | 84.1 | ||||||||||||
| Adjusted diluted earnings per share | $ | 0.52 | $ | 0.69 | ||||||||||
| Three Months Ended March 31, |
||||||||||||||
| 2026 | 2025 | |||||||||||||
| Diluted earnings (loss) per share as reported | $ | 0.34 | $ | (3.99) | ||||||||||
| EBIT adjustments total | 0.24 | 4.49 | ||||||||||||
| Tax impact of EBIT adjustments and other tax items | (0.08) | 0.18 | ||||||||||||
| Pension actuarial loss | 0.03 | — | ||||||||||||
| Write off of deferred financing costs upon repurchase of debt | — | 0.02 | ||||||||||||
| Impact of adjustments on noncontrolling interests | (0.01) | (0.01) | ||||||||||||
| Adjusted diluted earnings per share | $ | 0.52 | $ | 0.69 | ||||||||||
| Three Months Ended March 31, |
||||||||||||||
| (in millions) | 2026 | 2025 | ||||||||||||
| Equity income | $ | 13 | $ | 18 | ||||||||||
| Equity income adjustments: | ||||||||||||||
| Restructuring charges at affiliates | 1 | — | ||||||||||||
| Non-recurring loss at affiliates | — | 1 | ||||||||||||
| Equity income adjustments total | 1 | 1 | ||||||||||||
| Adjusted equity income | $ | 14 | $ | 19 | ||||||||||
| Three Months Ended March 31, |
||||||||||||||
| (in millions) | 2026 | 2025 | ||||||||||||
| Net financing charges | $ | 48 | $ | 48 | ||||||||||
| Interest expense adjustments: | ||||||||||||||
| Write off of deferred financing costs upon repurchase of debt | — | (2) | ||||||||||||
| Interest expense adjustments total | — | (2) | ||||||||||||
| Adjusted net financing charges | $ | 48 | $ | 46 | ||||||||||
| Three Months Ended March 31, |
Six Months Ended March 31, |
|||||||||||||||||||||||||
| (in millions) | 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||||
| Operating cash flow | $ | 81 | $ | (45) | $ | 161 | $ | 64 | ||||||||||||||||||
| Capital expenditures | (73) | (45) | (138) | (109) | ||||||||||||||||||||||
| Free cash flow | $ | 8 | $ | (90) | $ | 23 | $ | (45) | ||||||||||||||||||
| Three Months Ended March 31, |
Six Months Ended March 31, |
|||||||||||||||||||||||||
| (in millions) | 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||||
| Adjusted EBITDA | $ | 223 | $ | 233 | $ | 430 | $ | 429 | ||||||||||||||||||
| Adjusted equity income | (14) | (18) | (43) | (39) | ||||||||||||||||||||||
| Dividends from partially owned affiliates | 28 | 46 | 28 | 52 | ||||||||||||||||||||||
| Restructuring (cash) | (19) | (33) | (38) | (67) | ||||||||||||||||||||||
| Working capital | (79) | (207) | (40) | (146) | ||||||||||||||||||||||
| Interest paid | (43) | (33) | (97) | (87) | ||||||||||||||||||||||
| Cash taxes | (54) | (24) | (74) | (39) | ||||||||||||||||||||||
| Other | 39 | (9) | (5) | (39) | ||||||||||||||||||||||
| Capital expenditures | (73) | (45) | (138) | (109) | ||||||||||||||||||||||
| Free cash flow | $ | 8 | $ | (90) | $ | 23 | $ | (45) | ||||||||||||||||||
| March 31, | September 30, | |||||||||||||
| (in millions) | 2026 | 2025 | ||||||||||||
| Numerator: | ||||||||||||||
| Short-term debt | $ | — | $ | 2 | ||||||||||
| Current portion of long-term debt | 9 | 9 | ||||||||||||
| Long-term debt | 2,379 | 2,386 | ||||||||||||
| Total debt | 2,388 | 2,397 | ||||||||||||
| Less: cash and cash equivalents | 831 | 958 | ||||||||||||
| Net debt | $ | 1,557 | $ | 1,439 | ||||||||||
| Denominator: | ||||||||||||||
| Adjusted EBITDA - last four quarters | ||||||||||||||
| Q1 2025 | na | $ | 196 | |||||||||||
| Q2 2025 | na | 233 | ||||||||||||
| Q3 2025 | 226 | 226 | ||||||||||||
| Q4 2025 | 226 | 226 | ||||||||||||
| Q1 2026 | 207 | na | ||||||||||||
| Q2 2026 - see table (a) & (b) | 223 | na | ||||||||||||
| Last four quarters | $ | 882 | $ | 881 | ||||||||||
| Net leverage ratio | 1.77 | 1.63 | ||||||||||||
| Three Months Ended March 31, |
||||||||||||||
| (in millions) | 2026 | 2025 | ||||||||||||
| Restructuring related charges | $ | (5) | $ | (5) | ||||||||||
| Restructuring charges at affiliates | (1) | — | ||||||||||||
| $ | (6) | $ | (5) | |||||||||||
| Three Months Ended March 31, |
||||||||||||||
| (in millions) | 2026 | 2025 | ||||||||||||
| Non-recurring reserve release | $ | 5 | $ | — | ||||||||||
| Transaction costs | (1) | — | ||||||||||||
| Consulting costs associated with strategic planning | — | (8) | ||||||||||||
| Non-recurring loss at an affiliate | — | (1) | ||||||||||||
| $ | 4 | $ | (9) | |||||||||||